Anti-PD-L1/TGF-beta Trap (M7824) Alone and in Combination With TriAd Vaccine and N-803 for Resectable Head and Neck Squamous Cell Carcinoma Not Associated With Human Papillomavirus Infection
Phase 1/2 Completed
21 enrolled 16 charts
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation
Completed
32 enrolled
Pioglitazone Hydrochloride in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Phase 2 Completed
21 enrolled 6 charts
Study to Evaluate the Natural History of Head and Neck Cancer Precursors in Taiwan
Completed
3,576 enrolled
Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck Cancer
Phase 1 Completed
3 enrolled
PS-341 and Radiation to Treat Advanced Cancer of the Head and Neck
Phase 1 Completed
25 enrolled
Effect of AdhAQP1 on Salivary Flow in Patients Treated With Radiation for Head and Neck Cancer
Phase 1 Completed
17 enrolled
Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma
Phase 1/2 Completed
37 enrolled 6 charts
A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
48 enrolled 14 charts
Salivary Proteins in Disease and Health
Completed
264 enrolled
S0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Phase 2 Completed
42 enrolled 8 charts
Immunotoxin Therapy in Treating Patients With Advanced Cancer
Phase 1 Completed
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
Phase 1 Completed
Vaccine Therapy in Treating Patients With Advanced or Recurrent Cancer
Phase 1 Completed
Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer
Phase NA Completed
Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules
Phase NA Completed
400 enrolled
Surgery and Radiation Therapy Compared With Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer That Can Be Removed During Surgery
Phase 3 Completed
200 enrolled
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
Phase 1 Completed
Endoscopic Surgery or Radiation Therapy in Treating Patients With Stage 0, Stage I, or Stage II Laryngeal Cancer of the Glottis
Phase 2 Completed
50 enrolled
Sargramostim to Prevent Mucositis in Patients Receiving Radiation Therapy for Laryngeal Cancer
Phase 2 Completed
Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
Phase 3 Completed
Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Thyroid Cancer
Phase 2 Completed
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Mouth Cancer
Phase 1/2 Completed
Radiation Therapy in Treating Patients With Head and Neck Cancer
Phase 3 Completed
460 enrolled
Combination Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
Phase 3 Completed
Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
Phase 2 Completed
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
Interleukin-2 Gene or Methotrexate in Treating Patients With Recurrent or Refractory Stage III or Stage IV Head and Neck Cancer
Phase 2 Completed
Computer-Assisted Scheduling of Nicotine Inhaler Use in Participants Who Plan to Stop Smoking
Phase NA Completed
Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or Hypopharynx
Phase 2 Completed
50 enrolled
Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Phase 2 Completed
60 enrolled
BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Phase 1/2 Completed
27 enrolled
Thalidomide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Phase 2 Completed
47 enrolled
Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Patients With Central Nervous System Cancer
Phase 2 Completed
30 enrolled
Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer
Phase 2 Completed
Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
Phase 1 Completed
30 enrolled
Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
Phase 1/2 Completed
Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer
Phase 1 Completed
46 enrolled
Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
45 enrolled
PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation Therapy
Phase NA Completed
40 enrolled
Radiation Therapy Plus Porfiromycin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 3 Completed
600 enrolled
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
Phase 2 Completed
Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer
Phase 1 Completed
48 enrolled
A Pilot Study of Paclitaxel With Radiation Therapy for Locally Advanced Head and Neck Cancer
Phase 1 Completed
35 enrolled
Structure and Functional Status of Parotid Glands Exposed to Therapeutic Irradiation
Completed
20 enrolled
The Effects of Upper Airway and Digestive Tract Tumors on the Immune System
Completed
93 enrolled
Potential of Transplanted Stem Cells to Mature Into Salivary Gland and Cheek Cells
Completed
10 enrolled